Search alternatives:
mg decrease » we decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
nn decrease » mean decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
150 mg » 10 mg (Expand Search), 100 mg (Expand Search), 50 mg (Expand Search)
12 nn » 12 nm (Expand Search)
mg decrease » we decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
nn decrease » mean decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
150 mg » 10 mg (Expand Search), 100 mg (Expand Search), 50 mg (Expand Search)
12 nn » 12 nm (Expand Search)
-
1
FTY720 treatment decreased tumor growth in a xenograft model of hepatoblastoma.
Published 2019“…When tumors reached an average of 150 mm<sup>3</sup>, mice were randomized to receive vehicle (ORA-Plus, 50 μL, n = 7) or FTY720 (10 mg/kg body weight/day in ORA-Plus, 50 μL, n = 7) by oral gavage for 16 days. …”
-
2
-
3
-
4
Baseline characteristics of women by randomization method<sup>$</sup> (mITT analysis).
Published 2024Subjects: -
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
Decreased oscillatory flow decreases <i>klf2a</i> expression.
Published 2009“…<p>(A) RFF is decreased by alterations in heart rate. …”
-
15
Decreased macrophage recruitment correlates with decreased angiogenesis.
Published 2013“…<p>A) Quantification of BrdU incorporation demonstrates that decreased macrophage infiltration does not significantly correlate with a change in epithelial cell proliferation (N.S. = not significant). …”
-
16
-
17
-
18
-
19
-
20
Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.
Published 2016“…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”